Journal of Molecular Medicine

BPC-STUDY-P021

Hsieh MJ, et al. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. Journal of Molecular Medicine. 2017;95:323–333. DOI: 10.1007/s00109-016-1488-y. PMID: 27847966.

Study design

Record details

Design: Compound reference

Evidence record

Endpoints, findings, and limitations

Limitations

This study record is an evidence-index entry. Interpret the design, material, population or model, endpoints, findings, and limitations only within the linked approved source and compound evidence map; do not transfer outcomes across compounds, materials, cohorts, or models.

Reports and sources

Reference ledger

P021Compound reference

Journal of Molecular Medicine

Hsieh MJ, et al. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. Hsieh MJ, et al. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. Journal of Molecular Medicine. 2017;95:323–333. DOI: 10.1007/s00109-016-1488-y. PMID: 27847966.(2017). DOI: 10.1007/s00109-016-1488-y